11 September 2025

Genus plc

Director/PDMR Shareholding

Genus plc (LSE: GNS) announces that on 10 September 2025, conditional share awards were granted under the Genus 2019 Performance Share Plan ('PSP') over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT') as listed in table A below.  In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ended 30 June 2025, share awards were granted over ordinary shares under the Genus 2019 Deferred Share Bonus Plan ('DSBP') as listed in table B below.

Details of the performance conditions that apply to the conditional share awards can be found in the Directors' Remuneration Report of the Genus 2025 Annual Report which will be published next month.

The price at which PSP and DSBP share awards have been granted was determined in accordance with the PSP and DSBP rules.

Genus further announces that:

·    in accordance with the terms of joining contained in his employment contract, Andy Russell, Chief Financial Officer, was granted contingent rights over 9,014 ordinary shares in Genus under an individual award agreement with a normal vesting date of 10 September 2027;

·    in accordance with the terms of joining contained in her employment contract, Lucie Grant, Group General Counsel and Company Secretary was granted contingent rights over 1,351 ordinary shares in Genus under an individual award agreement with a normal vesting date of 17 March 2027;

·    Matt Culbertson, Chief Operating Officer PIC, was granted contingent rights over 12,610 ordinary shares in Genus under an individual award agreement with a normal vesting date of 10 September 2028; and

·    Jim Low, Chief Operating Officer ABS, was granted contingent rights over 12,610 ordinary shares in Genus under an individual award agreement with a normal vesting date of 10 September 2028,

as listed in table C below.

Subject to the terms of the individual award agreements and continued service, the awards will vest on the normal vesting dates as specified above.

No consideration was paid for the grant of these awards and no consideration is due in connection with the vesting of these awards.

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail of the nil-cost option awards made on 10 September 2025.

For further information please contact:

Genus:

Vaughn Walton, Deputy Company Secretary                                       Tel: +44 (0)1256 347100

Table A - GELT 2019 Performance Share Plan Options

Table B - GELT 2019 Deferred Share Bonus Plan Options

Table C - Restricted Stock Awards